Buy this Article for $5.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.


  1. Aschenbrenner, Diane S. MS, RN


* Remdesivir (Veklury) is the first antiviral drug approved to treat patients ages 12 and older who are hospitalized with COVID-19.


* The drug is administered via slow IV infusion.


* Elevated liver enzymes are common with treatment. Hypersensitivity reactions, including anaphylaxis, are possible.